Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells Therapy, Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, No. 62, Dr. Gharib's Street, Keshavarz Boulevard, 1419433151, Tehran, Iran.
Adv Exp Med Biol. 2021;1345:103-118. doi: 10.1007/978-3-030-82735-9_9.
During the past decades, diverse methods have been used toward renal tissue engineering in order to replace renal function. The goals of all these techniques included the recapitulation of renal filtration, re-absorptive, and secretary functions, and replacement of endocrine/metabolic activities. It is also imperative to develop a reliable, up scalable, and timely manufacturing process. Decellularization of the kidney with intact ECM is crucial for in-vivo compatibility and targeted clinical application. Contemporarily there is an increasing interest and research in the field of regenerative medicine including stem cell therapy and tissue bioengineering in search for new and reproducible sources of kidneys. In this chapter, we sought to determine the most effective method of renal decellularization and recellularization with emphasis on biologic composition and support of stem cell growth. Current barriers and limitations of bioengineered strategies will be also discussed, and strategies to overcome these are suggested.
在过去的几十年中,已经使用了多种方法来进行肾脏组织工程,以替代肾功能。所有这些技术的目标都包括重新实现肾脏的过滤、再吸收和分泌功能,以及替代内分泌/代谢功能。开发一种可靠、可扩展和及时的制造工艺也是至关重要的。用完整的细胞外基质对肾脏进行去细胞化对于体内相容性和靶向临床应用至关重要。目前,再生医学领域,包括干细胞治疗和组织生物工程,对寻找新的、可重复的肾脏来源的兴趣和研究日益增加。在本章中,我们试图确定最有效的肾脏去细胞化和再细胞化方法,重点是生物成分和支持干细胞生长。还将讨论生物工程策略的当前障碍和局限性,并提出克服这些障碍的策略。